Insider · CIK 0002014301
Fisher Andrew
Reports to the SEC for 1 company · LONDON, X0
Transactions
30
Companies
1
Filings
5
CIK
0002014301
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-10-07 | VRNAVerona Pharma plcD Disposition to Issuer | — |
| 2025-10-07 | VRNAVerona Pharma plcM Exercise/Conversion | — |
| 2025-10-07 | VRNAVerona Pharma plcD Disposition to Issuer | — |
| 2025-10-07 | VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion | — |
| 2025-10-07 | VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion | — |
| 2025-10-07 | VRNAVerona Pharma plc · Restricted Share UnitA Award | — |
| 2025-10-07 | VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion | — |
| 2025-10-07 | VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer | — |
| 2025-08-01 | VRNAVerona Pharma plcM Exercise/Conversion | — |
| 2025-08-01 | VRNAVerona Pharma plcS Sale | −$126K |
| 2025-08-01 | VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-07-08 | VRNAVerona Pharma plcF Tax Payment | −$452K |
| 2025-07-07 | VRNAVerona Pharma plcM Exercise/Conversion | — |
| 2025-07-07 | VRNAVerona Pharma plc · Restricted Share UnitsA Award | — |
| 2025-07-07 | VRNAVerona Pharma plc · Restricted Share UnitsM Exercise/Conversion | — |
| 2025-06-16 | VRNAVerona Pharma plcM Exercise/Conversion | +$161K |
| 2025-06-16 | VRNAVerona Pharma plcS Sale | −$922K |
| 2025-06-16 | VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion | — |
| 2025-05-15 | VRNAVerona Pharma plcM Exercise/Conversion | +$161K |
| 2025-05-15 | VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion | — |
| 2025-05-15 | VRNAVerona Pharma plcM Exercise/Conversion | +$169K |
| 2025-05-15 | VRNAVerona Pharma plcS Sale | −$686K |
| 2025-05-15 | VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion | — |
| 2025-04-29 | VRNAVerona Pharma plcM Exercise/Conversion | — |
| 2025-04-29 | VRNAVerona Pharma plcS Sale | −$234K |
| 2025-04-29 | VRNAVerona Pharma plc · Restricted Share UnitsA Award | — |
| 2025-04-29 | VRNAVerona Pharma plc · Restricted Share UnitsM Exercise/Conversion | — |
| 2025-03-19 | VRNAVerona Pharma plcG Gift | — |
| 2024-10-30 | VRNAVerona Pharma plcA Award | — |
| 2024-04-01 | VRNAVerona Pharma plc · Share Options (Right to Buy)A Award | — |
Recent filings
- 4Fisher Andrew0001104659-25-097967SEC(opens sec.gov)
- 4Fisher Andrew0001104659-25-074399SEC(opens sec.gov)
- 4Fisher Andrew0001104659-25-066764SEC(opens sec.gov)
- 4Fisher Andrew0001104659-25-060652SEC(opens sec.gov)
- 4/AFisher Andrew0001104659-25-060648SEC(opens sec.gov)
Companies
Address
3 MORE LONDON RIVERSIDE
LONDON, X0, SE1 2RE